Literature DB >> 17202769

Increased nitrosative and oxidative stress in platelets of migraine patients.

Gülsen Yilmaz1, Hatice Sürer, Levent E Inan, Ozlem Coskun, Dogan Yücel.   

Abstract

The molecular mechanisms of migraine have not been fully clarified yet. Increased nitrosative and oxidative stress may be associated with migraine attacks. Platelets may play an important role in migraine patients and they can reflect the lability of tissues to nitrosative/oxidative stress. In the present study, we aimed to determine the levels of nitrosative and oxidative stress markers in platelets of migraine patients during headache-free and attack periods. A total of 56 subjects (22 migraine without aura, 14 migraine with aura, and 20 age- and sex-matched healthy controls) were included in the study and nitric oxide (NO) metabolites, malondialdehyde (MDA), and thiol (SH) groups were measured in platelets. During migraine attacks, platelet levels of nitrate, nitrite and MDA were significantly higher in migraineurs than these in control subjects (p = 0.042, p = 0.005 and p = 0.042, respectively). By contrast, during headache-free period, no statistically significant differences were found in the platelet levels of nitrate, nitrite and MDA between migraineurs and controls (p > 0.05), although the marginal increases were detected in migraineurs. These results suggest that increased biomarkers of nitrosative and oxidative stress in platelets may be important in migraine patients, especially during attacks; increase of NO metabolites in platelets during attacks supports the opinion that NO may play a modulatory role in biological processes particularly by vasodilatation in migraine attacks. Therefore, MDA and NO metabolites may serve as useful markers to show the increased vulnerability to nitrosative and oxidative stress in migraine patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202769     DOI: 10.1620/tjem.211.23

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  18 in total

1.  Paraoxonase 1 (PON1) polymorphisms and risk for migraine.

Authors:  Elena García-Martín; Carmen Martínez; Mercedes Serrador; Hortensia Alonso-Navarro; Francisco Navacerrada; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

2.  The association between dietary tryptophan intake and migraine.

Authors:  Soodeh Razeghi Jahromi; Mansoureh Togha; Zeinab Ghorbani; Azita Hekmatdoost; Faezeh Khorsha; Pegah Rafiee; Pedram Shirani; Morvarid Nourmohammadi; Hossein Ansari
Journal:  Neurol Sci       Date:  2019-06-28       Impact factor: 3.307

3.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

4.  Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.

Authors:  Ravi Gupta; Rahul Pathak; Manjeet Singh Bhatia; Basu Deb Banerjee
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

5.  Decreased antioxidant status in migraine patients with brain white matter hyperintensities.

Authors:  Bilal Aytaç; Özlem Coşkun; Bülent Alioğlu; Zahide Esra Durak; Süleyman Büber; Esra Tapçi; Ruhşen Ocal; Levent Ertuğrul Inan; İlker Durak; Tahir Kurtuluş Yoldaş
Journal:  Neurol Sci       Date:  2014-07-10       Impact factor: 3.307

6.  White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study.

Authors:  Zhenyang Zheng; Zijian Xiao; Xiaolei Shi; Minghui Ding; Wei Di; Weiwei Qi; Aiwu Zhang; Yannan Fang
Journal:  J Neurol       Date:  2014-02-18       Impact factor: 4.849

7.  Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Seyed Ali Sonbolestan; Kiyan Heshmat; Shaghayegh Haghjooy Javanmard; Mohammad Saadatnia
Journal:  Int J Prev Med       Date:  2013-01

8.  Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine.

Authors:  Ertugrul Uzar; Osman Evliyaoglu; Gülten Toprak; Abdullah Acar; Yavuz Yucel; Tugba Calisir; Mehmet Ugur Cevik; Nebahat Tasdemir
Journal:  J Headache Pain       Date:  2011-02-27       Impact factor: 7.277

Review 9.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

10.  Altered Metabolites in the Occipital Lobe in Migraine Without Aura During the Attack and the Interictal Period.

Authors:  Luping Zhang; Jinwen Huang; Zhengxiang Zhang; Zhijian Cao
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.